+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05789394

Phase 1 Study of Safety and Dose Finding for Allogeneic Adipose-Derived Mesenchymal Stem Cells in Treating Recurrent Glioblastoma and Astrocytoma During Brain Surgery

Led by Mayo Clinic · Updated on 2026-04-02

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, side effects, and best dose of allogenic adipose-derived mesenchymal stem cells AMSCs for patients with recurrent glioblastoma or astrocytoma undergoing brain surgery. Glioblastoma is the most common and aggressive brain tumor, and despite standard treatments like surgery, radiation, chemotherapy, and tumor treating fields, survival remains low with frequent recurrence. This phase I trial aims to explore whether AMSCs delivered directly into the surgical cavity during craniotomy can affect tumor growth and improve outcomes. Participants receive AMSCs injected into the tumor area during a craniotomy, along with placement of an Ommaya reservoir to collect cerebrospinal fluid CSF. Patients undergo magnetic resonance imaging MRI and provide blood, tissue, and CSF samples throughout the study. The study follows a dose-escalation design to determine the maximum tolerated dose of AMSCs. During the trial, participants are monitored closely with MRI scans and sample collections to assess safety, immune response, and tumor behavior. Follow-up visits occur every two months for one year to evaluate adverse effects, progression-free survival, and overall survival. The research also looks at changes in brain tissue over time and presence of AMSCs at recurrence, with safety monitored up to five years.

CONDITIONS

Brief Title

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Research Team

C

Clinical Trials Referral Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here